Howland Jonathan, Rohsenow Damaris J, Minsky Sara, Snoberg Jan, Tagerud Sven, Hunt Sarah K, Almeida Alissa, Greece Jacey, Allensworth-Davies Donald
Department of Social and Behavioral Sciences, Boston University School of Public Health, 715 Albany Street, Boston, MA 02118, USA.
Int J Occup Environ Health. 2008 Oct-Dec;14(4):250-6. doi: 10.1179/oeh.2008.14.4.250.
Transdermal scopolamine is commonly used by mariners to prevent or treat seasickness. Most studies indicate that scopolamine administered transdermally via an adhesive patch does not impair performance of skills required to navigate a vessel, but trials have not been conducted testing navigation and ship handling under realistic conditions. The aim of this study was to test the effects of transdermal scopolamine on performance using training simulators to assess complex vessel navigation and rough-weather ship handling abilities. A randomized double-blind crossover study assessed 32 Swedish maritime cadets under transdermal scopolamine and placebo conditions on simulated navigation and ship handling performance, sleepiness, and subjective measures of fitness and performance. There were no significant differences on occupational outcomes by medication condition, but sustained reaction time was significantly increased under transdermal scopolamine, relative to placebo. We conclude that the transdermal scopolamine patch does not impair simulated ship handling.
透皮东莨菪碱常用于海员预防或治疗晕船。大多数研究表明,通过粘贴片经皮给药的东莨菪碱不会损害驾驶船只所需技能的表现,但尚未在实际条件下进行测试导航和船舶操控的试验。本研究的目的是使用训练模拟器来评估复杂的船舶导航和恶劣天气下的船舶操控能力,以测试透皮东莨菪碱对表现的影响。一项随机双盲交叉研究评估了32名瑞典海事学员在透皮东莨菪碱和安慰剂条件下的模拟导航和船舶操控表现、嗜睡程度以及健康和表现的主观指标。用药情况对职业结果没有显著差异,但与安慰剂相比,透皮东莨菪碱治疗下持续反应时间显著增加。我们得出结论,透皮东莨菪碱贴片不会损害模拟船舶操控能力。